WellPoint Downgrade Weighing on IHF Tuesday, October 26, 11:15 AM ET, by Market News Video Staff This morning, Citigroup downgraded shares of WellPoint (WLP) from buy to hold citing valuation. Citigroup ...
REGN Announces Positive Trial Results Monday, November 22, 1:34 PM ET, by Market News Video Staff Regeneron Pharmaceuticals (REGN) shares are trading higher today after it and Bayer HealthCare announced positive ...
SLV, FXH: Big ETF Inflows Tuesday, May 17, 10:47 AM ET, by Market News Video Staff Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF ...
On 6/13/11, Pharmaceutical Product Development Inc. (PPDI) will trade ex-dividend, for its quarterly dividend of $0.15, payable on 6/29/11. As a percentage of PPDI's recent stock price of $26.68, this dividend works out to approximately 0.56%.
Below is a dividend history chart for PPDI, showing historical dividends prior to the most recent $0.15 declared by Pharmaceutical Product Development Inc.:
PPDI Dividend History
Date
Div*
03/11/11
0.150
12/13/10
0.150
09/13/10
0.150
06/11/10
0.150
06/02/10
1.466
03/11/10
0.150
12/11/09
0.150
09/11/09
0.150
06/11/09
0.150
03/11/09
0.125
12/11/08
0.125
09/11/08
0.100
06/10/08
0.100
03/12/08
0.100
12/12/07
0.100
09/12/07
0.030
06/12/07
0.030
03/12/07
0.030
12/12/06
0.030
09/12/06
0.025
06/12/06
0.025
03/09/06
0.025
10/13/05
0.525
* Data may be adjusted for splits; we are not responsible for data errors; always verify data with the company.
In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from PPDI is likely to continue, and whether the current estimated yield of 2.25% on annualized basis is a reasonable expectation of annual yield going forward.
PPDI operates in the Biotechnology sector, among companies like Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) which is off about 1.7% today, and Dendreon Corp (NASDAQ:DNDN) trading lower by about 0.3%. Below is a three month price history chart comparing the stock performance of PPDI, versus REGN and DNDN.
In Thursday trading, Pharmaceutical Product Development Inc. shares are currently off about 0.3% on the day.
The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors —
anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset
allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors,
commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow
the performance trail wherever it leads us.
This Article's Word Cloud:BelowBiotechnologyChannelDDDDDDDNDNDevelopmentDividendFFFFFFNASDAQPPDIPharmaceuticalPharmaceuticalsProductREGNThursdayaboutallowsalwaysassetchartcompanycompletelycurrentlydatadesigneddividenddividendsescapefillColorgridColorgrowthhistoryleftLabelsEverylikelymostotherperformanceportfoliopricerecentresponsibleshowingstockstocksthistradingwhatwhetherwhichyield
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.